FIBROGEN

fibrogen-logo

FibroGen is a research-based biotechnology company using its expertise in connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology to discover, develop, and commercialize novel therapeutics for serious unmet medical needs. The company applies its pioneering expertise in hypoxia-inducible factor (HIF), connective tissue growth factor (CTGF) biology, and clinical development to advance innovative medicines for the treatment of anemia, fibrotic disease, and cancer. FibroGe... n's product Roxadustat is an oral small-molecule inhibitor of HIF prolyl hydroxylase activity in worldwide Phase 3 clinical development for the treatment of anemia in chronic kidney disease (CKD), with a New Drug Application currently under review in China by the State Drug Administration or SDA (formerly the China Food and Drug Administration).
#People #Financial #Event #Website #More

FIBROGEN

Social Links:

facebook

Facebook

linkedin

Linkedin

Industry:
Biopharma Biotechnology Health Care Therapeutics

Founded:
1993-01-01

Address:
San Francisco, California, United States

Country:
United States

Website Url:
http://www.fibrogen.com

Total Employee:
251+

Status:
Active

Contact:
415-978-1200

Email Addresses:
[email protected]

Total Funding:
188.02 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible LetsEncrypt Apple Mobile Web Clips Icon Content Delivery Network Domain Not Resolving Sitelinks Search Box IPv6 Google Maps GStatic Google Static Content



Current Advisors List

james-a-schoeneck_image

James A. Schoeneck Board of Directors @ FibroGen
Board_member

not_available_image

Julian N. Stern Board of Directors @ FibroGen
Board_member

rory-riggs_image

Rory Riggs Board of Directors @ FibroGen
Board_member

not_available_image

Thomas F. Kearns Board of Directors @ FibroGen
Board_member

not_available_image

Miguel Madero Board of Directors @ FibroGen
Board_member

not_available_image

Toshinari Tamura Board of Directors @ FibroGen
Board_member

not_available_image

Roberto Pedro Rosenkranz Board of Directors @ FibroGen
Board_member

jorma-routti_image

Jorma Routti Board of Directors @ FibroGen
Board_member

Current Employees Featured

juan-graham_image

Juan Graham
Juan Graham CFO @ FibroGen
CFO
2021-08-01

not_available_image

Michael D. Lowenstein
Michael D. Lowenstein Chief Legal Officer, Corporate Secretary & Compliance Officer @ FibroGen
Chief Legal Officer, Corporate Secretary & Compliance Officer
2002-01-01

not_available_image

Leanne C. Price
Leanne C. Price Vice President, Intellectual Property and Corporate Strategy @ FibroGen
Vice President, Intellectual Property and Corporate Strategy

not_available_image

Ted Tucker
Ted Tucker Vice President, Human Resources @ FibroGen
Vice President, Human Resources
1997-09-01

not_available_image

Michael Martinelli
Michael Martinelli VP Technical Development @ FibroGen
VP Technical Development
2011-03-01

not_available_image

James W. Polarek
James W. Polarek Vice President @ FibroGen
Vice President
1995-07-01

not_available_image

Kalevi Kurkijärvi
Kalevi Kurkijärvi Director @ FibroGen
Director
1995-12-01

not_available_image

Al Lin
Al Lin Vice President, Preclinical Development and Chemical Manufacturing and Control (CMC) @ FibroGen
Vice President, Preclinical Development and Chemical Manufacturing and Control (CMC)

john-hunter_image

John Hunter
John Hunter Chief Scientific Officer @ FibroGen
Chief Scientific Officer

danna-liu_image

Danna Liu
Danna Liu Senior Manager, Financial Reporting @ FibroGen
Senior Manager, Financial Reporting
2020-02-01

Founder


not_available_image

Thomas Neff

Stock Details


Company's stock symbol is NASDAQ:FGEN

Investors List

astrazeneca_image

AstraZeneca

AstraZeneca investment in Post-IPO Equity - FibroGen

apothecary-capital_image

Apothecary Capital

Apothecary Capital investment in Venture Round - FibroGen

sigma-capital_image

Sigma Capital Group

Sigma Capital Group investment in Venture Round - FibroGen

astellas-pharma_image

Astellas Pharma

Astellas Pharma investment in Venture Round - FibroGen

biofund-management_image

BioFund Management

BioFund Management investment in Venture Round - FibroGen

corriente-biotechnology-partners_image

Corriente Biotechnology Partners

Corriente Biotechnology Partners investment in Venture Round - FibroGen

adage-capital-management_image

Adage Capital Management

Adage Capital Management investment in Venture Round - FibroGen

duquesne-capital-management_image

Duquesne Capital Management

Duquesne Capital Management investment in Venture Round - FibroGen

rosewood-corporation_image

Rosewood Corporation

Rosewood Corporation investment in Venture Round - FibroGen

t-rowe-price_image

T. Rowe Price

T. Rowe Price investment in Venture Round - FibroGen

Newest Events participated

clinical-operations-strategy-meeting-west-coast-2018_event_image Participated in Clinical Operations Strategy Meeting West Coast 2018 on 2018-05-15 as speaker

Key Employee Changes

Date New article
2021-08-16 FibroGen Announces Retirement of Pat Cotroneo and Appointment of Juan Graham as Chief Financial Officer

Official Site Inspections

http://www.fibrogen.com Semrush global rank: 1.82 M Semrush visits lastest month: 12.44 K

  • Host name: 147.62.236.23.bc.googleusercontent.com
  • IP address: 23.236.62.147
  • Location: Mountain View United States
  • Latitude: 37.4043
  • Longitude: -122.0748
  • Metro Code: 807
  • Timezone: America/Los_Angeles
  • Postal: 94043

Loading ...

More informations about "FibroGen" on Search Engine